3-cyanobenzimidamide | 140658-21-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-cyanobenzimidamide
• 英文别名: 3-cyanobenzene-1-carboximidamide；3-cyanobenzenecarboximidamide
• CAS: 140658-21-5
• 化学式: C₈H₇N₃
• mdl: MFCD11052469
• 分子量: 145.164
• InChiKey: LYULTZNQVUBBGE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  73.7
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-bromo-1-(2-phenylpyrimidin-5-yl)ethanone 、 3-cyanobenzimidamide 以 四氢呋喃 、 水 为溶剂， 反应 1.0h， 生成
  参考文献：
  名称：

  新型酰胺和咪唑化合物作为有效的造血前列腺素D 2合酶抑制剂

  摘要：

  在寻找新颖且有效的小分子造血前列腺素D 2合酶（H-PGDS）抑制剂作为PGD 2介导的疾病和病症的潜在疗法时，我们探索了一系列包括多个以线性排列方式连接的芳基/杂芳基环的化合物。每种化合物在嘧啶或吡啶的“核”环与“尾”环系统之间都掺入了酰胺或咪唑“连接基”。我们通过荧光偏振结合测定，热位移测定，谷胱甘肽S-转移酶抑制测定和基于细胞的测定LPS诱导的PGD 2抑制的测定合成和筛选了二十个类似物。刺激。酰胺类似物在存在谷胱甘肽（GSH）的情况下，在热位移测定中显示的位移是在没有GSH的情况下进行的相同测定的十倍。咪唑类似物在两种测定条件之间没有产生明显的热位移变化，表明合成酶-GSH-抑制剂复合物中酰胺连接基可能具有稳定作用。咪唑模23，（KMN-010034）表明横跨优越效力的体外测定和良好的体外在人和豚鼠肝脏微粒体代谢稳定性。

  DOI：

  10.1016/j.bmcl.2020.127759

文献信息

• [EN] 4-PHENYL-N-(PHENYL)THIAZOL-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS<br/>[FR] DÉRIVÉS DE 4-PHÉNYL-N-(PHÉNYL)THIAZOL-2-AMINE ET COMPOSÉS ASSOCIÉS UTILISÉS COMME AGONISTES DU RÉCEPTEUR D'HYDROCARBURE ARYLE (AHR) POUR LE TRAITEMENT, PAR EX., DE TROUBLE LIÉS À L'ANGIOGENÈSE OU INFLAMMATOIRES
  申请人：IKENA ONCOLOGY INC

  公开号：WO2021127301A1

  公开（公告）日：2021-06-24

  4-phenyl-N-(phenyl)thiazol-2-amine and 4-(pyridin-3-yl)-N-( phenyl) thiazol-2-amine derivatives and the corresponding thiadiazole, thiophene, oxazole, oxadiazole, imidazole and triazole derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders.

  4-苯基-N-(苯基)噻唑-2-胺和4-(吡啶-3-基)-N-(苯基)噻唑-2-胺衍生物以及相应的噻二唑、噻吩、噁唑、噁二唑、咪唑和三唑衍生物和相关化合物作为芳香烃受体（AHR）激动剂，用于治疗涉及血管生成的疾病，例如视网膜病变、银屑病、类风湿性关节炎、肥胖和癌症，或炎症性疾病。
• [EN] PYRAZOLOTRIAZINES<br/>[FR] PYRAZOLOTRIAZINES
  申请人：BAYER AG

  公开号：WO2021116178A1

  公开（公告）日：2021-06-17

  The present invention provides compounds of general formula (I), in which X, R1, R2 and R3 are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, in particular of hyperproliferative disorders such as cancer disorders, as a sole agent or in combination with other active ingredients.

  本发明提供了具有通用公式（I）的化合物，其中X，R1，R2和R3如本文所述和定义，制备所述化合物的方法，用于制备所述化合物的有用中间化合物，包含所述化合物的药物组合物和组合，以及使用所述化合物用于制造用于治疗和/或预防疾病的药物组合物，特别是作为单一剂或与其他活性成分结合使用的过度增殖障碍，如癌症疾病。
• Direct, Late‐Stage Mono‐ <i>N</i> ‐arylation of Pentamidine: Method Development, Mechanistic Insight, and Expedient Access to Novel Antiparastitics against Diamidine‐Resistant Parasites
  作者：Jack Robertson、Marzuq A. Ungogo、Mustafa M. Aldfer、Leandro Lemgruber、Fergus S. McWhinnie、Bela E. Bode、Katherine L. Jones、Allan J. B. Watson、Harry P. Koning、Glenn A. Burley

  DOI：10.1002/cmdc.202100509

  日期：2021.11.19

  Accessing antiparasitic amidines: A selective mono-N-arylation strategy of amidines under Chan-Lam conditions was used to access the first mono-N-arylated analogues of pentamidine. Sub-micromolar activity against kinetoplastid parasites was observed for several analogues with no cross-resistance in pentamidine and diminazene-resistant trypanosome strains and against Leishmania mexicana. This work highlights

  获得抗寄生虫脒：在 Chan-Lam 条件下使用脒的选择性单N-芳基化策略获得了喷他脒的第一个单N-芳基化类似物。在喷他脒和耐二胺脒的锥虫菌株以及对墨西哥利什曼原虫没有交叉耐药性的几种类似物中观察到对动质体寄生虫的亚微摩尔活性。这项工作突出了 Chan-Lam 单N-芳基化在开发针对二脒抗性锥虫病和利什曼病的治疗线索的潜力。
• NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION
  申请人：Amasaki Ichiro

  公开号：US20120136098A1

  公开（公告）日：2012-05-31

  To provide a novel triazine-based compound exhibiting an ultraviolet blocking effect even in the long-wavelength region and being useful as an ultraviolet absorber with excellent light resistance, and to provide an ultraviolet absorber and a resin composition, which can maintain a long-wavelength ultraviolet-blocking effect for a long period of time. A compound represented by the following formula (1): wherein each of R 1a , R 1b , R 1c , R 1d and R 1e independently represents a hydrogen atom or a monovalent substituent excluding OH, provided that at least one substituent represents a substituent having a Hammett's σp value of 0.3 or more and substituents may combine with each other to form a ring, and each of R 1g , R 1h , R 1i , R 1j , R 1k , R 1m , R 1n and R 1p independently represents a hydrogen atom or a monovalent substituent, provided that substituents may combine with each other to form a ring.
• NEW TRIAZINE DERIVATIVE AND ULTRAVIOLET ABSORBER
  申请人：FUJIFILM Corporation

  公开号：US20140213703A1

  公开（公告）日：2014-07-31

  There is provided a new triazine-based compound which is useful as an ultraviolet absorber having excellent light resistance, heat resistance and ultraviolet ray shielding effect. A compound represented by the following general formula (1), in the general formula (1), L 1 represents a divalent to decavalent aromatic ring residue or a divalent to decavalent heterocycle residue, n 1 represents an integer of 2 to 10, X 1 represents a hydrogen atom or a substituent, R 1a , R 1b , R 1c and R 1d each independently represent a hydrogen atom or a substituent and may be bonded to each other to form a ring.